Back to BALYASNY ASSET MANAGEMENT L.P. BALYASNY ASSET MANAGEMENT L.P.

MNPRMNPR
5 quarters

Position history for BALYASNY ASSET MANAGEMENT L.P.BALYASNY ASSET MANAGEMENT L.P.'s holdings in MONOPAR THERAPEUTICS INC

BALYASNY ASSET MANAGEMENT L.P. holds 134,543 shares of MNPR (MONOPAR THERAPEUTICS INC), worth $12.5M as of 2026-Q2. The position was decreased (-1.4% shares). MNPR represents 0.0% of BALYASNY ASSET MANAGEMENT L.P.'s portfolio.

Current Value

$12.5M

Current Shares

134,543

Total Value Change

+$12.2M

Total Shares Change

+128,402

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
134,543
-1.4%
$12.5M0.0%$92.59
0
2026-Q1
Increased
136,443
+327.6%
$7.5M0.0%$51.88
44
2025-Q4
New
31,907
-
$2.1M0.0%$65.07
36
2025-Q2
Exited
0
-100.0%
$00.0%$33.60
0
2025-Q1
New
6,141
-
$223,5940.0%$40.33
32

Other major holders of MNPR: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., ADAGE CAPITAL PARTNERS GP, L.L.C.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used